Cutaneous Metastasis from Sacral Chordoma: A Case Report

Authors

Abstract:

Chordoma is a malignant, slow growing and locally aggressive tumor. It arises from remnants of the notochord and accounts for 1–4% of all primary bone tumors. They usually arise from anywhere along the spine, from base of the skull to the sacrococcygeal area and usually do not metastasize. Chordomas are slow-growing tumors which are not responsive to conventional chemotherapy or radiation. They are usually diagnosed late in the course of the disease, as they are low-grade tumors that show a slow progression. Complete surgical excision is the only therapeutic modality to offer a cure. We present a 48-year-old man with progressive paraparesis and disseminated cutaneous and lung metastases diagnosed as metastatic chordoma of the sacrum.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Humeral metastasis from a sacrococcygeal chordoma: a case report

INTRODUCTION Chordomas are rare tumors of the skeletal system that arise from an intra-osseous benign precursor of notochordal cells. They are mainly locally aggressive. However, metastases to other sites, including the humeri, resulting in pathological fractures have been reported. We report the case of a patient with a metastatic chordoma that produced a pathologic fracture of the humerus. ...

full text

Sacral chordoma – a report of two cases

Chordoma is a rare, slow growing but locally aggressive malignant tumor derived from primitive notochordal elements, and it is usually found in the sacrococcygeal area. Chordomas are difficult to excise completely because preservation of sacral stability and sacral nerve pathways to the rectum and bladder limit the extent of surgery. The role of adjuvant treatment is uncertain and surgery remai...

full text

On a Rare Cutaneous Metastasis from a Sacrococcygeal Chordoma

Chordomas are rare malignant tumors of notochordal origin and are rare locally aggressive ones with a metastatic potential. The skin rarely is seen as metastatic site. We describe a case of an adult woman with cutaneous metastasis of a primary sacral chordoma excised ten years before, which appeared as a painless cutaneous mass located in the dorsal region. Once removed, the surgical specimen w...

full text

Solitary skull metastasis from follicular thyroid carcinoma: a case report

Introduction: Follicular thyroid carcinoma (FTC) is the second most common malignant form of thyroid cancers. FTC is more common in women with a peak incidence in the fifth and sixth decades of life. Invasion into blood vessels may lead to distant metastasis to bone, lung, liver or elsewhere. FTC rarely manifests itself as a distant metastatic lesion, especially as solitary metastasis. Case r...

full text

Cutaneous Metastasis of Choriocarcinoma : A Case Report

Choriocarcinoma is one of the malignant tumors of trophoblastic cells characterized by the secretion of human chorionic gonadotrophin (hCG) (1-3). Cutaneous metastasis is a rare presentation of choriocarcinoma but a poor prognostic sign because it is associated only with widespread disease (3-5). A 52-yr-old female complaining of dyspnea for 2 months, presented with fingertip sized erythematous...

full text

Combined Therapy for Distant Metastasis of Sacral Chordoma

Chordomas are known as rare primary malign tumours that have formed from primitive notochord remains. Sacral chordomas grow slowly but locally and aggressively. Chordomas are locally invasive and have low tendency to metastasis and have a poor prognosis in long-term follow-up. Metastasis may be seen in a rate of 5-40% of the chordomas. Metastasis of chordomas is common in liver, lung, lymph nod...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 11  issue 3

pages  109- 110

publication date 2019-09

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023